Company Data
Cyclo Therapeutics Inc.
Ticker
CYTH
Current Price
$0.9098 -4.03%
Market Cap
$26.2M
Price Target
Refer to Report
Volume
87.1K
52wk Range
$0.55 - $1.92
Overview
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its lead drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.